TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15534246

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 2356

Group type: EXPERIMENTAL
Intervention: Statin use in participants with at least one APOE-epsilon4 allele who entered the study before age 80
Number of subjects: 2356
Study: 11521932

Group type: EXPERIMENTAL
Intervention: Low-energy shock-wave therapy (ESWT), 6,000 impulses (energy flux density, 0.11 mJ/mm2) in three sessions after local anaesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham ESWT, 6,000 impulses after local anaesthesia
Number of subjects: 40
Study: 9314428

Group type: EXPERIMENTAL
Intervention: Low mean arterial pressure (MAP) goal of < or = 92 mm Hg
Number of subjects: 548

Group type: COMPARATOR
Intervention: Usual blood pressure group
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Low MAP goal
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Both blood pressure groups combined
Number of subjects: 548
Study: 8420275

Group type: EXPERIMENTAL
Intervention: Electrohydraulic lithotripter
Number of subjects: 60

Group type: COMPARATOR
Intervention: Piezoelectric lithotripter
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both lithotripters
Number of subjects: 60
Study: 3946248

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 to 300 mg/day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pindolol (5 to 15 mg/day)
Number of subjects: 39
Study: 28881294

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 482
Study: 26890894

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 24452085

Group type: EXPERIMENTAL
Intervention: Electrical calf muscle stimulation (EMS) with Veinoplus device for >100 minutes per day (>5 sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group with graduated middle stretch compression bandage and low dose unfractionated heparin (LDUH) injections
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Electrical calf muscle stimulation (EMS) with Veinoplus device
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patients with baseline thrombosis who underwent EMS
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group without EMS
Number of subjects: 80
Study: 22166961

Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Counseling with handout
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Counseling with video
Number of subjects: 45
Study: 20044067

Group type: EXPERIMENTAL
Intervention: Electronic prescription for calcium carbonate with vitamin D supplement
Number of subjects: 245

Group type: COMPARATOR
Intervention: Verbal counseling about calcium supplementation
Number of subjects: 245
Study: 19080566

Group type: EXPERIMENTAL
Intervention: AutoCPAP treatment for 1 month
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ASV treatment for 1 week
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Plasma TNF-alpha levels
Number of subjects: 50
Study: 16719171

Group type: EXPERIMENTAL
Intervention: Ifosphamide (IF) treatment in doses from 1.5 g/m2 to 3 g/m2 for 3 to 5 days.
Number of subjects: 76
Study: 12869359

Group type: EXPERIMENTAL
Intervention: Oxygen (3 L/minute)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Air (3 L/minute)
Number of subjects: 29
Study: 10868714

Group type: EXPERIMENTAL
Intervention: Easi-Breathe inhaler
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Autohaler inhaler
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pressurized metered dose inhaler (pMDI)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Clickhaler inhaler
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Accuhaler inhaler
Number of subjects: 100

Group type: COMPARATOR
Intervention: pMDI
Number of subjects: 100
Study: 8647496

Group type: EXPERIMENTAL
Intervention: Classical ultrasonography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasonography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasonography with compression test
Number of subjects: 0
Study: 2067212

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Chronic uremic patients undergoing their first dialysis session
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody (mAb) against human IL-6
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dialysis (first session and subsequent sessions)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Nature of dialysis membrane (cellulosic or synthetic polyacrilonitrile)
Number of subjects: 48
Study: 6437128

Group type: EXPERIMENTAL
Intervention: Danazol 400 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Danazol 600 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Danazol 800 mg
Number of subjects: 12
Study: 30040706

Group type: EXPERIMENTAL
Intervention: Active ultrasound therapy in addition to hotpack, TENS, and exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham ultrasound in addition to hotpack, TENS, and exercise
Number of subjects: 30
Study: 26822613

Group type: EXPERIMENTAL
Intervention: AVX-470 (0.2, 1.6 or 3.5g/day)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: AVX-470 (3.5g/day)
Number of subjects: 37
Study: 24485476

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 22280514

Group type: EXPERIMENTAL
Intervention: SMARTSteps-ONLY
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: SMARTSteps-PLUS
Number of subjects: 362

Group type: COMPARATOR
Intervention: Wait-list
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: SMARTSteps-ONLY and SMARTSteps-PLUS
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 362
Study: 20630656

Group type: EXPERIMENTAL
Intervention: Combination therapy of morphine with an NMDA‐receptor antagonist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine and placebo
Number of subjects: 0
Study: 17506978

Group type: EXPERIMENTAL
Intervention: Rumination task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Distraction task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative rumination task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive rumination task
Number of subjects: 0
Study: 16142134

Group type: EXPERIMENTAL
Intervention: Delayed pushing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate pushing
Number of subjects: 0
Study: 12518850

Group type: EXPERIMENTAL
Intervention: Sulfadoxine‐pyrimethamine (SP) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 0
Study: 9706827

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy administered in prehospital setting (Gr.1)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Thrombolytic therapy administered in hospital setting (Gr.2)
Number of subjects: 280
Study: 7633137

Group type: EXPERIMENTAL
Intervention: Skin-to-skin with the mother
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cot care for the first 45 min, then skin-to-skin with the mother
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cot care
Number of subjects: 0
Study: 2653174

Group type: EXPERIMENTAL
Intervention: Clonidine (0.3 mg per os)
Number of subjects: 10
Study: 9291

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg/day
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 50 mg/day
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 100 mg/day
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 200 mg/day
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31486103

Group type: EXPERIMENTAL
Intervention: Vortioxetine for 6 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 80
Study: 30616461

Group type: EXPERIMENTAL
Intervention: Postprandial glycemia
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fetuin-A
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Baseline calcium score
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Calcium score at 18 months
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 45
Study: 29798418

Group type: EXPERIMENTAL
Intervention: Recombinant human IL‐11 treatment
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional chemoradiotherapy
Number of subjects: 78
Study: 24441395

Group type: EXPERIMENTAL
Intervention: Modular individualized rehabilitation program (IG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional rehabilitation program (CG)
Number of subjects: 30
Study: 23118268

Group type: EXPERIMENTAL
Intervention: 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV)
Number of subjects: 780

Group type: COMPARATOR
Intervention: 7-valent pneumococcal conjugate vaccine (7vCRM)
Number of subjects: 780
Study: 21649812

Group type: EXPERIMENTAL
Intervention: Essential oil of lavender aroma exposure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 18317856

Group type: EXPERIMENTAL
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both VCV and PCV
Number of subjects: 24
Study: 16503773

Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.03% travoprost
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.004% bimatoprost
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (Group 4, artificial tears)
Number of subjects: 120
Study: 16808700

Group type: EXPERIMENTAL
Intervention: Interactive display
Number of subjects: 24

Group type: COMPARATOR
Intervention: Customized leaflet
Number of subjects: 24
Study: 11157688

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 2647

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2647
Study: 9446392

Group type: EXPERIMENTAL
Intervention: Tension-free mesh-plug repair (Lichtenstein in Rutkow's modification)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bassini procedure
Number of subjects: 100
Study: 7936516

Group type: EXPERIMENTAL
Intervention: 2-mg intravaginal prostaglandin E2 (PGE2) suppositories
Number of subjects: 80
Study: 3585441

Group type: EXPERIMENTAL
Intervention: Adr 70 mg/m2 IV day 1 and every 3 weeks
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Adr 20 mg/m2 IV day 1, 2, and 3, and 15 mg/m2 IV day 8 and weekly thereafter
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Adr 60 mg/m2 IV day 1 and DTIC 250 mg/m2 days 1 to 5, repeated every 3 weeks
Number of subjects: 316

Group type: COMPARATOR
Intervention: Adr weekly
Number of subjects: 316

Group type: COMPARATOR
Intervention: DTIC
Number of subjects: 316
Study: 31189455

Group type: EXPERIMENTAL
Intervention: Students
Number of subjects: 646

Group type: COMPARATOR
Intervention: Faculty and Staff
Number of subjects: 646
Study: 29533252

Group type: EXPERIMENTAL
Intervention: Aquatic therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Land-based aerobic exercise
Number of subjects: 32
Study: 28625402

Group type: EXPERIMENTAL
Intervention: Catheter-based delivery of fluid paclitaxel after bare metal stenting (DDB+BMS group)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Drug eluting stent (DES group)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Everolimus eluting stent (EES subgroup)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Paclitaxel eluting stent (PES subgroup)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: DDB+BMS group
Number of subjects: 68

Group type: COMPARATOR
Intervention: EES subgroup
Number of subjects: 68

Group type: COMPARATOR
Intervention: PES subgroup
Number of subjects: 68
Study: 26609037

Group type: EXPERIMENTAL
Intervention: Low intensity exercise and whole body vibration (WBV) training, 3 times a week for 10 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (routine life)
Number of subjects: 34
Study: 23390553

Group type: EXPERIMENTAL
Intervention: Blood pressure lowering
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Intensive blood glucose control
Number of subjects: 11140
Study: 21968667

Group type: EXPERIMENTAL
Intervention: 3% oregano extract ointment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Petrolatum
Number of subjects: 40
Study: 19009747

Group type: EXPERIMENTAL
Intervention: Betaferon (8 MIU every other day for 2 years)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Betaferon
Number of subjects: 58
Study: 16817643

Group type: EXPERIMENTAL
Intervention: Daily activities (sitting, walking, running, jumping)
Number of subjects: 0
Study: 12838499

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) combined with cyclosporine (CSA) and prednisone
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Tacrolimus compared with cyclosporine (CSA)
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Tacrolimus in combination with MMF
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Immunosuppressive therapy with MMF
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Common complications (chronic allograft nephropathy, hypertension, hyperlipidemia, bone disease)
Number of subjects: 100000
Study: 10714836

Group type: EXPERIMENTAL
Intervention: Lower body forced air warming
Number of subjects: 26

Group type: COMPARATOR
Intervention: Upper body forced air warming
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both upper and lower body forced air warming
Number of subjects: 26
Study: 9363861

Group type: EXPERIMENTAL
Intervention: Intensive-course 5-FU plus l-leucovorin with I.V. leucovorin (100 mg/m2)
Number of subjects: 926

Group type: EXPERIMENTAL
Intervention: Intensive-course 5-FU plus oral (d,l)-leucovorin (125 mg/m2)
Number of subjects: 926

Group type: EXPERIMENTAL
Intervention: Intensive-course 5-FU plus I.V. (d,l)-leucovorin (200 mg/m2)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Overall response rate for patients with measurable disease
Number of subjects: 926

Group type: COMPARATOR
Intervention: Grade III to IV toxic effects
Number of subjects: 926
Study: 8239918

Group type: EXPERIMENTAL
Intervention: Vratizolin (3% hydrophilic cream or ointment, four times daily)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Standard treatment (zinc ointment, Aphtin, Oxycort, Dicortinef)
Number of subjects: 193
Study: 3699121

Group type: EXPERIMENTAL
Intervention: Fenoterol powder inhaler with fast inhalation (16-19 l/min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fenoterol powder inhaler with breath-holding pause of 10 seconds
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal children (150 children aged 3.5-15 years)
Number of subjects: 10
Study: 29514921

Group type: EXPERIMENTAL
Intervention: High Physical and Sexual Violence and Injuries class
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: High Physical and Low Sexual Violence and Injuries class
Number of subjects: 947

Group type: COMPARATOR
Intervention: Low Physical and Sexual Violence class
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Overall working women reporting work-related disruption due to IPV
Number of subjects: 947
Study: 27166242

Group type: EXPERIMENTAL
Intervention: Hypobaric hypoxia (HH)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (NH)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control condition (NN)
Number of subjects: 13
Study: 24725808

Group type: EXPERIMENTAL
Intervention: Stiripentol 500 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Stiripentol 1000 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Stiripentol 2000 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Stiripentol (all doses)
Number of subjects: 12
Study: 23740460

Group type: EXPERIMENTAL
Intervention: CCL19 levels in RA patients
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: CXCL13 levels in RA patients
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Chemokine levels in RA patients
Number of subjects: 208
Study: 20834165

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum No. 14 (LP14) at a dosage of 8.7×10(8)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum No. 14 (LP14)
Number of subjects: 0
Study: 17689732

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg b.i.d.)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 15842286

Group type: EXPERIMENTAL
Intervention: PgE(2) 1 mg
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: PgE(2) 2 mg
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: PgE(2) groups
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Maternal and neonatal morbidity
Number of subjects: 332
Study: 11831913

Group type: EXPERIMENTAL
Intervention: 2'7'‐bis‐(2‐carboxyethyl)‐5‐(and‐6)‐carboxyfluorescein, acetoxymethyl ester (80 microg) applied via subconjunctival injection 15 minutes prior to trabeculectomy, followed by intraoperative illumination with diffuse blue light (450‐490 nm) for 8 minutes
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 10
Study: 10980843

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 0
Study: 8613282

Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg daily for 5 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Metronidazole 7.5 mg/kg thrice daily for 5 days
Number of subjects: 62
Study: 2125241

Group type: EXPERIMENTAL
Intervention: Gallopamil infusion (0.03 mg/kg bolus followed by continuous infusion at 0.02 mg/kg/h for the first 24 hours and 0.03 mg/kg/h for the last 48 hours)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Gallopamil infusion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Gallopamil withdrawal
Number of subjects: 9
Study: 161694

Group type: EXPERIMENTAL
Intervention: Plasminogen given I.V. at birth
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Urokinase activated human plasmin
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Plasminogen recipient group
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Plasmin inhibitors measured with a functional assay
Number of subjects: 500
Study: 30284385

Group type: EXPERIMENTAL
Intervention: Topical cyclosporine-A 2% eye drops
Number of subjects: 33

Group type: COMPARATOR
Intervention: Prednisolone acetate 1% eye drops
Number of subjects: 33
Study: 28359309

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo electroacupuncture
Number of subjects: 144
Study: 26530718

Group type: EXPERIMENTAL
Intervention: JinQi Jiangtang tablets
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 23302358

Group type: EXPERIMENTAL
Intervention: Essential oils‐containing antiseptic mouthrinse
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo rinsing
Number of subjects: 139
Study: 21070228

Group type: COMPARATOR
Intervention: Topiramate plus placebo injections
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA injections plus placebo tablets
Number of subjects: 59
Study: 19577745

Group type: EXPERIMENTAL
Intervention: Ethanol lavage
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline solution lavage
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 42
Study: 17645403

Group type: COMPARATOR
Intervention: Combined intervention (patient and physician education)
Number of subjects: 13455

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 13455
Study: 10925503

Group type: EXPERIMENTAL
Intervention: Ceramic veneer restorations with coronal height reduced to 7.5 mm (Group A)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ceramic veneer restorations with coronal height reduced to 6.5 mm (Group B)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ceramic veneer restorations with coronal height reduced to 5.5 mm (Group C)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Experimental control with coronal height of 8.5 mm (Group D)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Independent group with intact incisal edge of enamel (Group E)
Number of subjects: 48
Study: 8810653

Group type: EXPERIMENTAL
Intervention: Cadralazine (single oral dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cadralazine (chronic phase)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1578085

Group type: COMPARATOR
Intervention: One true modified ECT followed by five sham ECTs
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Six true ECTs
Number of subjects: 24
Study: 3868306

Group type: EXPERIMENTAL
Intervention: Rectally administered diazepam (0.6 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31258108

Group type: EXPERIMENTAL
Intervention: Sucralose (780 mg/d for 7 days)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sucralose and Placebo (combined analysis)
Number of subjects: 34
Study: 29239260

Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Manual toothbrush
Number of subjects: 100
Study: 27901245

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) at 2 mA, with the cathode positioned in the supplementary motor cortex and the anode in the deltoid, applied for 4 weeks.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham intervention (control group).
Number of subjects: 44
Study: 25311296

Group type: EXPERIMENTAL
Intervention: Hormone therapy (including selective estrogen receptor modulators, selective estrogen receptor downregulators, and aromatase inhibitors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeting other components of pathologically activated intracellular signaling
Number of subjects: 0
Study: 22763312

Group type: EXPERIMENTAL
Intervention: 40 mg parecoxib
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 60